Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Frontiers in Medicine|December 15, 2017
Drug Repurposing for the Treatment of Acute Myeloid LeukemiaVibeke Andresen, Bjørn T GjertsenOncotarget|December 16, 2016
Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in acute myeloid leukemia (AML)Maria Omsland, Øystein Bruserud, Bjørn T Gjertsen, et al.Molecular Aspects of Medicine|August 3, 2010
Hijacking the T-cell communication network by the human T-cell leukemia/lymphoma virus type 1 (HTLV-1) p12 and p8 proteinsNancy Van Prooyen, Vibeke Andresen, Heather Gold, et al.Molecular Aspects of Medicine|March 25, 2010
HTLV-1 p13, a small protein with a busy agendaMicol Silic-Benussi, Roberta Biasiotto, Vibeke Andresen, et al.Frontiers in Pharmacology|May 28, 2020
Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic SignalingDaniele Mercatelli, Massimo Bortolotti, Vibeke Andresen, et al.ACS Chemical Biology|December 23, 2014
Interactions of the natural product (+)-avrainvillamide with nucleophosmin and exportin-1 Mediate the cellular localization of nucleophosmin and its AML-associated mutantsHerschel Mukherjee, Kok-Ping Chan, Vibeke Andresen, et al.Retrovirology|July 3, 2015
Identification of novel monocistronic HTLV-1 mRNAs encoding functional Rex isoformsFrancesca Rende, Ilaria Cavallari, Vibeke Andresen, et al.Journal of Virology|August 5, 2011
Major histocompatibility complex class II transactivator CIITA is a viral restriction factor that targets human T-cell lymphotropic virus type 1 Tax-1 function and inhibits viral replicationGiovanna Tosi, Greta Forlani, Vibeke Andresen, et al.Oncotarget|January 27, 2016
Hydroxyurea synergizes with valproic acid in wild-type p53 acute myeloid leukaemiaCalum Leitch, Tereza Osdal, Vibeke Andresen, et al.British Journal of Haematology|November 25, 2024
Preclinical activity of resazurin in acute myeloid leukaemiaTrung Quang Ha, Vibeke Andresen, Bjarte Skoe Erikstein, et al.Pageof 3